Search
for
Sort by
Research 211–240 of 1000+
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Regulatory roles of androgens in cutaneous wound healing
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Chapter 23. Therapeutic Control of Androgen Action
- Androgens in SARS-CoV-2 Coronavirus Infections
- Hormonal Treatment for Skin Androgen-Related Disorders
- The role of androgens in hormone replacement therapy
- Androgens and androgen receptor action in skin and hair follicles
- The therapeutic use of androgens in women
- Androgens and the Menopause
- Tumor Necrosis Factor-Alpha and Polycystic Ovarian Syndrome: A Clinical, Biochemical, and Molecular Genetic Study
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- The Case of the Elusive Androgen
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Suety and Spreading-Stromal Hyperplasia and Hyperthecosis Ovary
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women